{"id":"cmvpp65-a-0201-peptide-vaccine","safety":{"commonSideEffects":[{"rate":"10%","effect":"Injection site pain"},{"rate":"8%","effect":"Fatigue"},{"rate":"6%","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL4297811","moleculeType":"Vaccine component"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This vaccine works by stimulating an immune response against the CMV pp65 antigen, which is a protein expressed by the cytomegalovirus.","oneSentence":"Activates cytotoxic T cells against CMV pp65 antigen","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T03:08:17.754Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Cytomegalovirus infection"}]},"trialDetails":[{"nctId":"NCT02396134","phase":"PHASE2","title":"Vaccine Therapy in Reducing the Frequency of Cytomegalovirus Events in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"2015-05-21","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission","enrollment":61},{"nctId":"NCT00712634","phase":"PHASE1","title":"Cytomegalovirus Vaccine in Healthy Participants","status":"COMPLETED","sponsor":"City of Hope Medical Center","startDate":"1997-11","conditions":"Precancerous/Nonmalignant Condition","enrollment":46}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2177,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CMVpp65-A*0201 peptide vaccine","genericName":"CMVpp65-A*0201 peptide vaccine","companyName":"City of Hope Medical Center","companyId":"city-of-hope-medical-center","modality":"Biologic","firstApprovalDate":"","aiSummary":"Activates cytotoxic T cells against CMV pp65 antigen Used for Cytomegalovirus infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}